GlassScriptPhysician profile
Benzy James Padanilam
NPI 1750350419
$28,761.50
in general payments reported to CMS, 2019-2025
16 companies · $3,632 in 2025
The $3,632 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,700 · 2020: $2,690 · 2021: $8,498 · 2022: $1,830 · 2023: $5,109 · 2024: $2,302 · 2025: $3,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,967 · Consulting Fee: $3,088 · Travel and Lodging: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,967.44 |
| Consulting Fee | $3,087.50 |
| Travel and Lodging | $988.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Topera, INC. | $11,307.40 | 2019-2021 | |
| Abbott Laboratories | $10,078.14 | 2019-2025 | Ensite, Advisor, Ensite Precision |
| Medtronic, INC. | $3,522.56 | 2021-2025 | Affera Mapping System, Micra, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $2,371.01 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Therapies, Emblem Mri S-Icd |
| Atricure, INC. | $316.18 | 2021-2023 | |
| Biosense Webster, INC. | $210.29 | 2021-2024 | Carto 3 |
| Impulse Dynamics (USA) INC. | $183.41 | 2024 | Optimizer |
| Volta Medical INC | $170.09 | 2024 | Vx1 |
| Cardiva Medical, INC. | $160.97 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Medtronic Vascular, INC. | $145.93 | 2019 | |
| Sanofi-Aventis U.S. LLC | $125.00 | 2019 | |
| Philips North America LLC | $122.55 | 2024 | (9520) Igt Devices Undivided |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.22 | 2025 | Lifevest |
| Cvrx, INC. | $16.04 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $14.71 | 2024 | Arcalyst |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benzy Padanilam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.